The Severity of Pain in Prostate Biopsy Depends on the Biopsy Sector

• Published in: Journal of personalized medicine 2023-02, Vol.13 (3), p.431
• Main Authors: Rempega, Grzegorz, Rajwa, Paweł, Kępiński, Michał, Ryszawy, Jakub, Wojnarowicz, Jakub, Kowalik, Maksymilian, Krzempek, Marcela, Krzywon, Aleksandra, Dobrakowski, Michał, Paradysz, Andrzej, Bryniarski, Piotr
• Format: Article
• Language: English
• Subjects: Age; Analgesia; Asymptomatic; Biopsy; Ethnicity; Family medical history; Hyperplasia; Malignancy; Medical research; Medicine, Experimental; Pain; Pain perception; Patients; Precision medicine; Prostate; Prostate cancer; Questionnaires; Radiation therapy; Statistical analysis; Stress; Ultrasonic imaging
• ISSN: 2075-4426; 2075-4426
• DOI: 10.3390/jpm13030431

The pain experienced by a patient during a prostate fusion biopsy is cumulative and can also be modulated by many factors. The aim of the study was to assess the association between the degree of pain intensity during prostate biopsy and the region of the biopted organ. The study included a group of 143 patients who underwent prostate fusion biopsy under local analgesia followed by blockage of the periprostatic nerve. After a biopsy, the patients completed the original questionnaire about the pain experienced during the procedure. There was a statistically significant difference in pain score between cores taken in the apex (median 5 (IQR 2-5)), medium level (median 1 (IQR 1-2)), and prostate base (median 1 (IQR 1-3)) ( < 0.001). The malignancy scale ISUP ≥ 2 ( = 0.038) and lower PSA value (r = -0.17; = 0.046) are associated with higher pain during procedure. Biopsy time was correlated with discomfort (r = 0.19; = 0.04). Age ( = 0.65), lesion size ( = 0.29), PI-RADS score ( = 0.86), prostate volume ( = 0.22), and the number of cores ( = 0.56) did not correspond to the pain scale. The apex is the most sensitive sector of the prostate. ISUP ≥ 2 and patients with low PSA levels more often indicated higher values on the pain rating scale.